LNTH News and Press, Lantheus Holdings Inc. From 05/01/24

2024-05-01 11:47:14 ET More on Lantheus Lantheus Holdings: Undervalued With A Good Outlook Lantheus Holdings, Inc. (LNTH) Q4 2023 Earnings Call Transcript Lantheus Q4 2023 Earnings Preview Seeking Alpha’s Quant Rating on Lantheus Historical ear...

BEDFORD, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, May 2, 2024, to discuss its financial and operating results for the first quarte...

2024-04-16 16:24:42 ET Summary The healthcare sector is overvalued by 14% based on 11-year averages. Healthcare providers are not far from their valuation baseline, while the most overvalued subsector is healthcare equipment. Fast facts on Fidelity MSCI Health Care Index ETF, ...

2024-04-12 05:51:00 ET Stocks like Sky Harbour (NYSEMKT: SKYH) and Lantheus Holdings (NASDAQ: LNTH) aren't exactly household names. In fact, they are small, overlooked businesses, but our experts don't think they'll stay that way for long. In this video, longtime Fool.com co...

2024-04-10 14:18:47 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Every investor should pay attention to Russell 2000 stocks with strong buy ratings. These stocks tend to have lower valuations compared to the highly-priced large-cap stocks in the FAANG group ...

2024-04-03 02:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-03-19 08:19:47 ET More on Fusion Pharmaceuticals Fusion Pharmaceuticals' Partnerships Strengthen Long-Term Outlook Biggest stock movers today: FUSN, NCMI, crypto stocks and more AstraZeneca will buy Fusion Pharmaceuticals for ~$2B Seeking Alpha’s ...

BEDFORD, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced Paul Blanchf...

BEDFORD, Mass., March 04, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow ® disease to deliver better patient outcomes, today announced t...

BEDFORD, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced the promotion...